Please provide your email address to receive an email when new articles are posted on . “The results of this study highlight concerns about the optimum time for grading corneal fluorescein staining,” ...

Please provide your email address to receive an email when new articles are posted on . In an analysis of data from two phase 3, multicenter studies of 1,217 adult patients randomized to the ...

Richard Adler, MD, FACS, leads a discussion on real-world signs, symptoms and patient reactions associated with the treatment for DED. This is a video synopsis/summary of a Post Conference ...

Richard Adler, MD, FACS, discusses the Switch trial which compared OTX-101 (cyclosporine ophthalmic solution 0.09%) vs cyclosporine ophthalmic emulsion 0.05% (Restasis) in patients with dry eye ...

Oculis is forging ahead with its precision medicine approach to treating dry eye disease, outlining plans to finalize a phase 3 study after seeing some signs of efficacy in a subpopulation in its ...